A股首份光伏组件企业中报出炉，身份“切换”爱旭股份二季度扭亏

Core Viewpoint - Aikang Co., Ltd. (爱旭股份) has shown significant improvement in its financial performance in the first half of 2025, driven by the success of its ABC components and cost reduction strategies [1][2][3]. Financial Performance - In the first half of 2025, Aikang Co., Ltd. achieved operating revenue of 8.446 billion yuan, a year-on-year increase of 63.63% [1]. - The net profit attributable to shareholders was -238 million yuan, an improvement from a loss of -1.745 billion yuan in the same period last year [1]. Component Sales and Market Strategy - The company reported that its ABC component shipments reached 8.57 GW, a year-on-year increase of over 400%, with ABC component revenue accounting for approximately 74% of total revenue, up from 32.96% in the previous year [2]. - Aikang Co., Ltd. is transitioning from a third-party battery supplier to a producer of advanced N-type ABC components and scenario-based products [2]. - In the second quarter of 2025, overseas sales of components accounted for over 40% of total sales, with ABC components commanding a price premium of 10% to 50% over traditional TOPCon components in high-value distributed markets [2]. Cost Management - The company has successfully reduced management expenses by 37.42% and R&D expenses by 65.60%, attributing these reductions to decreased personnel costs [3]. - Financial expenses shifted from 280 million yuan in the previous period to -37 million yuan, due to increased exchange gains and interest income [3]. Industry Outlook and Fundraising - Aikang Co., Ltd. noted that the industry is stabilizing due to self-regulatory production limits and improved pricing conditions, although potential risks remain if policy measures fall short [4]. - The company received approval for a revised fundraising plan, aiming to raise 3.5 billion yuan, with 3 billion yuan allocated for a new high-efficiency solar cell project and 500 million yuan for working capital [4]. - The fundraising is expected to enhance the supply capacity of N-type ABC cells and solidify the company's competitive advantage in the BC cell sector [4].